 | • レポートコード：MRC2-11QY11622 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は皮膚糸状菌性爪真菌症治療（DOT）のグローバル市場について調査・分析したレポートです。種類別（全身療法、局所療法、その他）市場規模、用途別（病院、皮膚科クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別皮膚糸状菌性爪真菌症治療（DOT）の競争状況、市場シェア ・世界の皮膚糸状菌性爪真菌症治療（DOT）市場：種類別市場規模 2015年-2020年（全身療法、局所療法、その他） ・世界の皮膚糸状菌性爪真菌症治療（DOT）市場：種類別市場規模予測 2021年-2026年（全身療法、局所療法、その他） ・世界の皮膚糸状菌性爪真菌症治療（DOT）市場：用途別市場規模 2015年-2020年（病院、皮膚科クリニック、その他） ・世界の皮膚糸状菌性爪真菌症治療（DOT）市場：用途別市場規模予測 2021年-2026年（病院、皮膚科クリニック、その他） ・北米の皮膚糸状菌性爪真菌症治療（DOT）市場分析：米国、カナダ ・ヨーロッパの皮膚糸状菌性爪真菌症治療（DOT）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの皮膚糸状菌性爪真菌症治療（DOT）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の皮膚糸状菌性爪真菌症治療（DOT）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの皮膚糸状菌性爪真菌症治療（DOT）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bausch Health Companies、Novartis AG、Johnson and Johnson、Galderma S.A.、Celtic Pharmaceuticals、Anacor Pharmaceuticals、Moberg Pharma AB、GlaxoSmithKline、Pfizer Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Dermatophytic onychomycosis, also known as tinea unguium, is a fungal disease of toenails or fingernails that causes ring infection over nails.
Dermatophytic onychomycosis could be treated with either topical preparations or oral antifungal agents based on the severity of infection. The treatment often lasts for an average period of six months. In recent past, advancement in therapy with the introduction of effective topical and oral products has controlled the rapid spread of dermatophytic onychomycosis.
Market Analysis and Insights: Global Dermatophytic Onychomycosis Treatment Market
The global Dermatophytic Onychomycosis Treatment market size is projected to reach US$ 1238.3 million by 2026, from US$ 1148.8 million in 2020, at a CAGR of 7.2%% during 2021-2026.
Global Dermatophytic Onychomycosis Treatment Scope and Market Size
Dermatophytic Onychomycosis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dermatophytic Onychomycosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bausch Health Companies
Novartis AG
Johnson and Johnson
Galderma S.A.
Celtic Pharmaceuticals
Anacor Pharmaceuticals
Moberg Pharma AB
GlaxoSmithKline
Pfizer Inc
Market segment by Type, the product can be split into
Systemic Therapy
Topical Therapy
Other
Market segment by Application, split into
Hospitals
Dermatology Clinics
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Dermatophytic Onychomycosis Treatment Revenue
1.4 Market by Type
1.4.1 Global Dermatophytic Onychomycosis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Systemic Therapy
1.4.3 Topical Therapy
1.4.4 Other
1.5 Market by Application
1.5.1 Global Dermatophytic Onychomycosis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Dermatology Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Dermatophytic Onychomycosis Treatment Market Perspective (2015-2026)
2.2 Global Dermatophytic Onychomycosis Treatment Growth Trends by Regions
2.2.1 Dermatophytic Onychomycosis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Dermatophytic Onychomycosis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Dermatophytic Onychomycosis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Dermatophytic Onychomycosis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Dermatophytic Onychomycosis Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Dermatophytic Onychomycosis Treatment Players by Market Size
3.1.1 Global Top Dermatophytic Onychomycosis Treatment Players by Revenue (2015-2020)
3.1.2 Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Dermatophytic Onychomycosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Dermatophytic Onychomycosis Treatment Market Concentration Ratio
3.2.1 Global Dermatophytic Onychomycosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Dermatophytic Onychomycosis Treatment Revenue in 2019
3.3 Dermatophytic Onychomycosis Treatment Key Players Head office and Area Served
3.4 Key Players Dermatophytic Onychomycosis Treatment Product Solution and Service
3.5 Date of Enter into Dermatophytic Onychomycosis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Dermatophytic Onychomycosis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Dermatophytic Onychomycosis Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Dermatophytic Onychomycosis Treatment Market Size by Application (2015-2020)
5.2 Global Dermatophytic Onychomycosis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Dermatophytic Onychomycosis Treatment Market Size (2015-2020)
6.2 Dermatophytic Onychomycosis Treatment Key Players in North America (2019-2020)
6.3 North America Dermatophytic Onychomycosis Treatment Market Size by Type (2015-2020)
6.4 North America Dermatophytic Onychomycosis Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Dermatophytic Onychomycosis Treatment Market Size (2015-2020)
7.2 Dermatophytic Onychomycosis Treatment Key Players in Europe (2019-2020)
7.3 Europe Dermatophytic Onychomycosis Treatment Market Size by Type (2015-2020)
7.4 Europe Dermatophytic Onychomycosis Treatment Market Size by Application (2015-2020)
8 China
8.1 China Dermatophytic Onychomycosis Treatment Market Size (2015-2020)
8.2 Dermatophytic Onychomycosis Treatment Key Players in China (2019-2020)
8.3 China Dermatophytic Onychomycosis Treatment Market Size by Type (2015-2020)
8.4 China Dermatophytic Onychomycosis Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Dermatophytic Onychomycosis Treatment Market Size (2015-2020)
9.2 Dermatophytic Onychomycosis Treatment Key Players in Japan (2019-2020)
9.3 Japan Dermatophytic Onychomycosis Treatment Market Size by Type (2015-2020)
9.4 Japan Dermatophytic Onychomycosis Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Dermatophytic Onychomycosis Treatment Market Size (2015-2020)
10.2 Dermatophytic Onychomycosis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Dermatophytic Onychomycosis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Dermatophytic Onychomycosis Treatment Market Size by Application (2015-2020)
11 India
11.1 India Dermatophytic Onychomycosis Treatment Market Size (2015-2020)
11.2 Dermatophytic Onychomycosis Treatment Key Players in India (2019-2020)
11.3 India Dermatophytic Onychomycosis Treatment Market Size by Type (2015-2020)
11.4 India Dermatophytic Onychomycosis Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Dermatophytic Onychomycosis Treatment Market Size (2015-2020)
12.2 Dermatophytic Onychomycosis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Dermatophytic Onychomycosis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Dermatophytic Onychomycosis Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bausch Health Companies
13.1.1 Bausch Health Companies Company Details
13.1.2 Bausch Health Companies Business Overview
13.1.3 Bausch Health Companies Dermatophytic Onychomycosis Treatment Introduction
13.1.4 Bausch Health Companies Revenue in Dermatophytic Onychomycosis Treatment Business (2015-2020))
13.1.5 Bausch Health Companies Recent Development
13.2 Novartis AG
13.2.1 Novartis AG Company Details
13.2.2 Novartis AG Business Overview
13.2.3 Novartis AG Dermatophytic Onychomycosis Treatment Introduction
13.2.4 Novartis AG Revenue in Dermatophytic Onychomycosis Treatment Business (2015-2020)
13.2.5 Novartis AG Recent Development
13.3 Johnson and Johnson
13.3.1 Johnson and Johnson Company Details
13.3.2 Johnson and Johnson Business Overview
13.3.3 Johnson and Johnson Dermatophytic Onychomycosis Treatment Introduction
13.3.4 Johnson and Johnson Revenue in Dermatophytic Onychomycosis Treatment Business (2015-2020)
13.3.5 Johnson and Johnson Recent Development
13.4 Galderma S.A.
13.4.1 Galderma S.A. Company Details
13.4.2 Galderma S.A. Business Overview
13.4.3 Galderma S.A. Dermatophytic Onychomycosis Treatment Introduction
13.4.4 Galderma S.A. Revenue in Dermatophytic Onychomycosis Treatment Business (2015-2020)
13.4.5 Galderma S.A. Recent Development
13.5 Celtic Pharmaceuticals
13.5.1 Celtic Pharmaceuticals Company Details
13.5.2 Celtic Pharmaceuticals Business Overview
13.5.3 Celtic Pharmaceuticals Dermatophytic Onychomycosis Treatment Introduction
13.5.4 Celtic Pharmaceuticals Revenue in Dermatophytic Onychomycosis Treatment Business (2015-2020)
13.5.5 Celtic Pharmaceuticals Recent Development
13.6 Anacor Pharmaceuticals
13.6.1 Anacor Pharmaceuticals Company Details
13.6.2 Anacor Pharmaceuticals Business Overview
13.6.3 Anacor Pharmaceuticals Dermatophytic Onychomycosis Treatment Introduction
13.6.4 Anacor Pharmaceuticals Revenue in Dermatophytic Onychomycosis Treatment Business (2015-2020)
13.6.5 Anacor Pharmaceuticals Recent Development
13.7 Moberg Pharma AB
13.7.1 Moberg Pharma AB Company Details
13.7.2 Moberg Pharma AB Business Overview
13.7.3 Moberg Pharma AB Dermatophytic Onychomycosis Treatment Introduction
13.7.4 Moberg Pharma AB Revenue in Dermatophytic Onychomycosis Treatment Business (2015-2020)
13.7.5 Moberg Pharma AB Recent Development
13.8 GlaxoSmithKline
13.8.1 GlaxoSmithKline Company Details
13.8.2 GlaxoSmithKline Business Overview
13.8.3 GlaxoSmithKline Dermatophytic Onychomycosis Treatment Introduction
13.8.4 GlaxoSmithKline Revenue in Dermatophytic Onychomycosis Treatment Business (2015-2020)
13.8.5 GlaxoSmithKline Recent Development
13.9 Pfizer Inc
13.9.1 Pfizer Inc Company Details
13.9.2 Pfizer Inc Business Overview
13.9.3 Pfizer Inc Dermatophytic Onychomycosis Treatment Introduction
13.9.4 Pfizer Inc Revenue in Dermatophytic Onychomycosis Treatment Business (2015-2020)
13.9.5 Pfizer Inc Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Dermatophytic Onychomycosis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Dermatophytic Onychomycosis Treatment Revenue
Table 3. Ranking of Global Top Dermatophytic Onychomycosis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Dermatophytic Onychomycosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Systemic Therapy
Table 6. Key Players of Topical Therapy
Table 7. Key Players of Other
Table 8. Global Dermatophytic Onychomycosis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Dermatophytic Onychomycosis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Dermatophytic Onychomycosis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Dermatophytic Onychomycosis Treatment Market Share by Regions (2015-2020)
Table 12. Global Dermatophytic Onychomycosis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Dermatophytic Onychomycosis Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Dermatophytic Onychomycosis Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Dermatophytic Onychomycosis Treatment Players
Table 19. Global Dermatophytic Onychomycosis Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Dermatophytic Onychomycosis Treatment Market Share by Players (2015-2020)
Table 21. Global Top Dermatophytic Onychomycosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatophytic Onychomycosis Treatment as of 2019)
Table 22. Global Dermatophytic Onychomycosis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Dermatophytic Onychomycosis Treatment Product Solution and Service
Table 25. Date of Enter into Dermatophytic Onychomycosis Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Dermatophytic Onychomycosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Dermatophytic Onychomycosis Treatment Market Size Share by Type (2015-2020)
Table 29. Global Dermatophytic Onychomycosis Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Dermatophytic Onychomycosis Treatment Market Size Share by Application (2015-2020)
Table 31. Global Dermatophytic Onychomycosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Dermatophytic Onychomycosis Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Dermatophytic Onychomycosis Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Dermatophytic Onychomycosis Treatment Market Share (2019-2020)
Table 35. North America Dermatophytic Onychomycosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Dermatophytic Onychomycosis Treatment Market Share by Type (2015-2020)
Table 37. North America Dermatophytic Onychomycosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Dermatophytic Onychomycosis Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Dermatophytic Onychomycosis Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Dermatophytic Onychomycosis Treatment Market Share (2019-2020)
Table 41. Europe Dermatophytic Onychomycosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Dermatophytic Onychomycosis Treatment Market Share by Type (2015-2020)
Table 43. Europe Dermatophytic Onychomycosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Dermatophytic Onychomycosis Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Dermatophytic Onychomycosis Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Dermatophytic Onychomycosis Treatment Market Share (2019-2020)
Table 47. China Dermatophytic Onychomycosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Dermatophytic Onychomycosis Treatment Market Share by Type (2015-2020)
Table 49. China Dermatophytic Onychomycosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Dermatophytic Onychomycosis Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Dermatophytic Onychomycosis Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Dermatophytic Onychomycosis Treatment Market Share (2019-2020)
Table 53. Japan Dermatophytic Onychomycosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Dermatophytic Onychomycosis Treatment Market Share by Type (2015-2020)
Table 55. Japan Dermatophytic Onychomycosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Dermatophytic Onychomycosis Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Dermatophytic Onychomycosis Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Dermatophytic Onychomycosis Treatment Market Share (2019-2020)
Table 59. Southeast Asia Dermatophytic Onychomycosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Dermatophytic Onychomycosis Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Dermatophytic Onychomycosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Dermatophytic Onychomycosis Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Dermatophytic Onychomycosis Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Dermatophytic Onychomycosis Treatment Market Share (2019-2020)
Table 65. India Dermatophytic Onychomycosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Dermatophytic Onychomycosis Treatment Market Share by Type (2015-2020)
Table 67. India Dermatophytic Onychomycosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Dermatophytic Onychomycosis Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Dermatophytic Onychomycosis Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Dermatophytic Onychomycosis Treatment Market Share (2019-2020)
Table 71. Central & South America Dermatophytic Onychomycosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Dermatophytic Onychomycosis Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Dermatophytic Onychomycosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Dermatophytic Onychomycosis Treatment Market Share by Application (2015-2020)
Table 75. Bausch Health Companies Company Details
Table 76. Bausch Health Companies Business Overview
Table 77. Bausch Health Companies Product
Table 78. Bausch Health Companies Revenue in Dermatophytic Onychomycosis Treatment Business (2015-2020) (Million US$)
Table 79. Bausch Health Companies Recent Development
Table 80. Novartis AG Company Details
Table 81. Novartis AG Business Overview
Table 82. Novartis AG Product
Table 83. Novartis AG Revenue in Dermatophytic Onychomycosis Treatment Business (2015-2020) (Million US$)
Table 84. Novartis AG Recent Development
Table 85. Johnson and Johnson Company Details
Table 86. Johnson and Johnson Business Overview
Table 87. Johnson and Johnson Product
Table 88. Johnson and Johnson Revenue in Dermatophytic Onychomycosis Treatment Business (2015-2020) (Million US$)
Table 89. Johnson and Johnson Recent Development
Table 90. Galderma S.A. Company Details
Table 91. Galderma S.A. Business Overview
Table 92. Galderma S.A. Product
Table 93. Galderma S.A. Revenue in Dermatophytic Onychomycosis Treatment Business (2015-2020) (Million US$)
Table 94. Galderma S.A. Recent Development
Table 95. Celtic Pharmaceuticals Company Details
Table 96. Celtic Pharmaceuticals Business Overview
Table 97. Celtic Pharmaceuticals Product
Table 98. Celtic Pharmaceuticals Revenue in Dermatophytic Onychomycosis Treatment Business (2015-2020) (Million US$)
Table 99. Celtic Pharmaceuticals Recent Development
Table 100. Anacor Pharmaceuticals Company Details
Table 101. Anacor Pharmaceuticals Business Overview
Table 102. Anacor Pharmaceuticals Product
Table 103. Anacor Pharmaceuticals Revenue in Dermatophytic Onychomycosis Treatment Business (2015-2020) (Million US$)
Table 104. Anacor Pharmaceuticals Recent Development
Table 105. Moberg Pharma AB Company Details
Table 106. Moberg Pharma AB Business Overview
Table 107. Moberg Pharma AB Product
Table 108. Moberg Pharma AB Revenue in Dermatophytic Onychomycosis Treatment Business (2015-2020) (Million US$)
Table 109. Moberg Pharma AB Recent Development
Table 110. GlaxoSmithKline Business Overview
Table 111. GlaxoSmithKline Product
Table 112. GlaxoSmithKline Company Details
Table 113. GlaxoSmithKline Revenue in Dermatophytic Onychomycosis Treatment Business (2015-2020) (Million US$)
Table 114. GlaxoSmithKline Recent Development
Table 115. Pfizer Inc Company Details
Table 116. Pfizer Inc Business Overview
Table 117. Pfizer Inc Product
Table 118. Pfizer Inc Revenue in Dermatophytic Onychomycosis Treatment Business (2015-2020) (Million US$)
Table 119. Pfizer Inc Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dermatophytic Onychomycosis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Systemic Therapy Features
Figure 3. Topical Therapy Features
Figure 4. Other Features
Figure 5. Global Dermatophytic Onychomycosis Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Dermatology Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Dermatophytic Onychomycosis Treatment Report Years Considered
Figure 10. Global Dermatophytic Onychomycosis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Dermatophytic Onychomycosis Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Dermatophytic Onychomycosis Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Dermatophytic Onychomycosis Treatment Market Share by Players in 2019
Figure 15. Global Top Dermatophytic Onychomycosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatophytic Onychomycosis Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Dermatophytic Onychomycosis Treatment Revenue in 2019
Figure 17. North America Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Dermatophytic Onychomycosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
皮膚糸状菌性爪真菌症治療薬（DOT）の世界市場（～2026年） Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs.…- 皮膚糸状菌性爪真菌症の世界市場（～2026年） Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes…
- 爪真菌症の世界市場（～2026年） Onychomycosis, also known as tinea unguium, is a fungal infection of the nail. Symptoms may include white or yellow nail discoloration, thickening of the nail, and separation of the nail from the nail bed. Toenails or fingernails may be affected, but it is more common for toenails to be affected. Co…
- 全身感染症治療の世界市場（～2026年） Systemic infection earns its name by being spread throughout the systems of the body. Systemic infections are not necessarily more severe than local infections. Market Analysis and Insights: Global Systemic Infection Treatment Market The global Systemic Infection Treatment market size is projected t…
- うつ病治療療法の世界市場（～2026年） Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest. One of the major factors for such low growth is a rapid decline in the revenue of branded drug manufacturers and growing strength of generic drug manufacturers. The introduction of virtual reality in the …